Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Sanofi Winthrop Industrie🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 2, 2025
Approval ID: ae3b7c57dd391a49
Company: Sanofi Winthrop Industrie
Type: Standard

Approval Details

Approval Id: ae3b7c57dd391a49
Drug Cima Aemps Name: APROVEL 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 97046027IP2
Holder Company Name: Sanofi Winthrop Industrie
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/99baacb72cdf1ab6/sanofi-winthrop-industrie
Authorization Date: 2025-04-02
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 300 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Sanofi Winthrop Industrie
Company Detail Path: /organization/99baacb72cdf1ab6/sanofi-winthrop-industrie

Company Information

Pharmaceutical Company Name: SANOFI WINTHROP INDUSTRIE
Country Name: France
City Name: amilly,centre val de loire,country_fr
Address: 130 RUE DE LA FONTAINE

Active Ingredients

IRBESARTAN

300 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 2, 2025

Approval ID

ae3b7c57dd391a49

Type

Standard

Back to CIMA-AEMPS Approvals